| CuraGen
Corporation, based in New Haven, Conn., is revolutionizing the discovery and
development of life science products through the systematic application of genomics.
CuraGen's fully-integrated genomics technologies, processes, and information systems are
designed to rapidly generate comprehensive information about gene expression, biological
pathways, and potential products that affect these pathways, each on a scale not
previously undertaken. The Company completed an Initial Public Offering on March 18, 1998. |
